Log In
Print
BCIQ
Print
Print this Print this
 

Opdivo (nivolumab) (BMS-936558, MDX-1106, ONO-4538)

  Manage Alerts
Collapse Summary General Information
Company Ono Pharmaceutical Co. Ltd.
DescriptionHuman IgG4 mAb against programmed cell death 1 (PDCD1; PD-1; CD279)
Molecular Target Programmed cell death 1 (PDCD1) (PD-1) (CD279)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today